Abstract
Immunohistochemistry of tumour samples is increasingly used in the triage of families where hereditary non-polyposis colorectal cancer (HNPCC) due to mismatch repair defects is suspected. Usually, this is undertaken in tumours that are a recognised part of the spectrum of HNPCC-related cancers e.g. colon or endometrial cancers. Although breast cancers are not classed as part of this spectrum, this study examined the extent to which some breast tumours do arise by the mismatch repair pathway in these families. This may have clinical utility in families where an individual with a ‘classic HNPPC-related’ tumour is not available for evaluation. Immunohistochemistry of a breast tumour may identify an individual in whom germline mutation testing is worthwhile.
References
Scott RJ, McPhillips M, Meldrum CJ et al (2001) Hereditary non-polyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 68:118–127. doi:10.1086/316942
Vasen HFA, Morreau H, Nortier JWR (2001) Is breast cancer part of the spectrum of hereditary non-polyposis colorectal cancer? Am J Hum Genet 68:1533–1535. doi:10.1086/320610
Vahteristo P, Ojala S, Tamminen A et al (2005) No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer. J Med Genet 42:e22. doi:10.1136/jmg.2004.022327
Barrow E, Robinson L, Aldhuaj W, Shenton A, Lalloo F, Hill J, Evans DG (2008) Extracolonic cancers in HNPCC: cumulative lifetime incidence and tumour distribution. A report of 121 families. Clin Genet (in press)
Risinger JI, Barrett JC, Watson P et al (1996) Molecular genetic evidence of occurrence of breast cancer as an integral tumor in patients with hereditary non-polyposis colorectal carcinoma syndrome. Cancer 77:1836–1843. doi:10.1002/(SICI)1097-0142(19960501)77:9<1836::AID-CNCR12>3.0.CO;2-0
Boyd J, Rhei E, Federici MG et al (1999) Male breast cancer in the hereditary non-polyposis colorectal cancer syndrome. Breast Cancer Res Treat 53:87–91. doi:10.1023/A:1006030116357
de Leeuw WJ, van Puijenbroek M, Tollenaar RA et al (2002) Correspondence re: A. Muller et al., Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res 63(5):1148–1149
Hendriks YM, Wagner A, Morreau H et al (2004) Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counselling and mutations. Gastroenterology 127:17–25. doi:10.1053/j.gastro.2004.03.068
Siah SP, Quinn DM, Bennett GD et al (2000) Microsatellite instability in breast cancer: a review and study showing MSI was not detected at BAT 25 and BAT 26 microsatellite markers in early-onset breast cancer. Breast Cancer Res Treat 60:135–142. doi:10.1023/A:1006315315060
Muller A, Edmonston TB, Corao DA et al (2002) Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res 62(4):1014–1019
Westenend PJ, Schutte R, Hoogmans MMCP et al (2005) Breast cancer in an MSH2 gene mutation carrier. Hum Pathol 36:1322–1326
Kirk JA (2006) How can we best detect hereditary non-polyposis colorectal cancer? New tumour testing methods can improve the accuracy of diagnosis. Med J Aust 84(5):206–207
Vasen HF, Watson P, Mecklin JP et al (1999) New clinical criteria for hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116(6):1453–1456
Levi S, Urbano-Ispizua A, Gill D et al (1991) Multiple K-ras 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 51:3497–3502
Boland CR, Thibodeau SN, Hamilton SR et al (1998) National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition:development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257
Data on breast risk from Breast Cancer Network Australia www.bcna.org.au
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shanley, S., Fung, C., Milliken, J. et al. Breast cancer immunohistochemistry can be useful in triage of some HNPCC families. Familial Cancer 8, 251–255 (2009). https://doi.org/10.1007/s10689-008-9226-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-008-9226-4